Pfizer Inc

مادة اعلانية

Latest Update: 27 Feb 2026 20:12 Abu Dhabi Time.

Market Status: Opened

PFE

Pfizer Inc

27.46

USD

0.360

1.33%

Open

27.18

Prev Close

27.10

PX_VOLUME

MARKET CAP (M)

DAY RANGE

27.10 - 27.47

52 WEEKS

20.92 - 27.94

Stock Statistics

Yearly Change

2.57%

Listed Shares (Million)

9,621.00

Earnings Multiple

19.92

Average 30-day trading volume

52,012,243.35

Price-to-book ratio

1.66

Earnings Per Share

1.36

Previous Dividend Distribution

1.72

Dividend Yield

6.35%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2025	Sep 28, 2025	Jun 29, 2025	Mar 30, 2025	Dec 31, 2024	Sep 29, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Oct 01, 2023
Total Revenue		17,557.00	16,654.00	14,653.00	13,715.00	17,763.00	17,702.00	13,283.00	14,879.00	14,569.00	13,491.00
Gross Profit		11,263.00	11,452.00	9,940.00	9,912.00	10,750.00	11,517.00	9,208.00	10,535.00	12,236.00	3,406.00
Operating Income		4,645.00	6,072.00	4,324.00	4,966.00	2,921.00	5,993.00	3,062.00	4,757.00	5,587.00	-2,399.00
Net Income		-1,640.00	3,550.00	2,903.00	2,974.00	411.00	4,481.00	31.00	3,128.00	-3,334.00	-2,388.00
Profit Margin		-9.34	21.32	19.81	21.68	2.31	25.31	0.23	21.02	-22.88	-17.70

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		62,579.00	63,627.00	59,553.00	101,175.00	81,288.00	41,651.00
Gross Profit		42,565.00	42,009.00	37,031.00	63,469.00	46,902.00	29,898.00
Operating Income		19,894.00	16,729.00	13,096.00	40,863.00	27,677.00	10,258.00
Net Income		7,786.00	8,051.00	2,173.00	31,401.00	22,459.00	6,666.00
Profit Margin		12.44	12.65	3.65	31.04	27.63	16.00

Balance Sheet

	Period Ending:	Sep 28, 2025	Jun 29, 2025	Mar 30, 2025	Dec 31, 2024	Sep 29, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Oct 01, 2023
Total Assets		208,731.00	206,095.00	208,028.00	213,396.00	219,476.00	216,193.00	221,095.00	226,501.00	215,021.00
Total Liabilities		115,635.00	117,083.00	117,391.00	124,899.00	126,918.00	128,218.00	128,537.00	137,213.00	117,817.00
Total Equity		93,096.00	89,012.00	90,637.00	88,497.00	92,558.00	87,975.00	92,558.00	89,288.00	97,204.00

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		213,396.00	226,501.00	197,205.00	181,476.00	154,229.00
Total Liabilities		124,899.00	137,213.00	101,289.00	104,014.00	90,756.00
Total Equity		88,497.00	89,288.00	95,916.00	77,462.00	63,473.00

Cash Flows Statements

	Period Ending:	Sep 28, 2025	Jun 29, 2025	Mar 30, 2025	Dec 31, 2024	Sep 29, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Oct 01, 2023
Cash From Operating Activities		4,604.00	-583.00	2,335.00	6,721.00	6,713.00	-1,780.00	1,090.00	5,239.00	3,461.00
Cash From Investing Activities		-2,430.00	3,951.00	3,274.00	-1,623.00	-2,057.00	4,600.00	1,732.00	-10,996.00	888.00
Cash From Financing Activities		-2,477.00	-3,196.00	-5,227.00	-5,114.00	-4,636.00	-2,459.00	-4,931.00	5,442.00	-3,779.00
Net Change in Cash		-301.00	213.00	375.00	-45.00	29.00	343.00	-2,137.00	-316.00	534.00

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		12,744.00	8,700.00	29,267.00	32,923.00	10,586.00
Cash From Investing Activities		2,652.00	-32,278.00	-15,783.00	-22,534.00	-4,189.00
Cash From Financing Activities		-17,140.00	26,066.00	-14,834.00	-9,816.00	-21,640.00
Net Change in Cash		-1,810.00	2,448.00	-1,515.00	159.00	475.00

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.